NASDAQ Panel Grants Pressure BioSciences’ Request for Continued Listing – MarketWatch (press release)
|
NASDAQ Panel Grants Pressure BioSciences' Request for Continued Listing
MarketWatch (press release) While the Company is working toward regaining compliance with all applicable requirements for continued listing on The NASDAQ Capital Market, including both the minimum stockholders' equity and the minimum bid price of $ 1.00 per share, there can be no … |
